Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?
Abdoulaye KarabouéPasquale F InnominatoNicholas I WreglesworthBoris DuchemannRené AdamFrancis A LéviPublished in: British journal of cancer (2024)
Such emerging understanding of circadian rhythms regulation of antitumour immunity now calls for randomised clinical trials of ICIs timing to establish recommendations for personalised chrono-immunotherapies with current and forthcoming drugs.